These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 22031218)
1. Notice of CDC's discontinuation of investigational pentavalent (ABCDE) botulinum toxoid vaccine for workers at risk for occupational exposure to botulinum toxins. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(42):1454-5. PubMed ID: 22031218 [TBL] [Abstract][Full Text] [Related]
2. Botulism and vaccines for its prevention. Smith LA Vaccine; 2009 Nov; 27 Suppl 4():D33-9. PubMed ID: 19837283 [TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity. Khouri JM; Motter RN; Arnon SS Vaccine; 2018 Apr; 36(15):2041-2048. PubMed ID: 29475762 [TBL] [Abstract][Full Text] [Related]
4. What next for botulism vaccine development? Webb RP; Smith LA Expert Rev Vaccines; 2013 May; 12(5):481-92. PubMed ID: 23659297 [TBL] [Abstract][Full Text] [Related]
5. Botulinum neurotoxin vaccines: Past history and recent developments. Rusnak JM; Smith LA Hum Vaccin; 2009 Dec; 5(12):794-805. PubMed ID: 19684478 [TBL] [Abstract][Full Text] [Related]
6. Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D. Moreira C; da Cunha CE; Moreira GM; Mendonça M; Salvarani FM; Moreira ÂN; Conceição FR Anaerobe; 2016 Aug; 40():58-62. PubMed ID: 27236078 [TBL] [Abstract][Full Text] [Related]
7. Progress toward development of an inhalation vaccine against botulinum toxin. Park JB; Simpson LL Expert Rev Vaccines; 2004 Aug; 3(4):477-87. PubMed ID: 15270652 [TBL] [Abstract][Full Text] [Related]
8. Pentavalent replicon vaccines against botulinum neurotoxins and tetanus toxin using DNA-based Semliki Forest virus replicon vectors. Yu YZ; Liu S; Ma Y; Gong ZW; Wang S; Sun ZW Hum Vaccin Immunother; 2014; 10(7):1874-9. PubMed ID: 25424795 [TBL] [Abstract][Full Text] [Related]
9. Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism. Webb RP; Smith TJ; Smith LA; Wright PM; Guernieri RL; Brown JL; Skerry JC Toxins (Basel); 2017 Sep; 9(9):. PubMed ID: 28869522 [TBL] [Abstract][Full Text] [Related]
10. Alternative vaccination against equine botulism (BoNT/C). Frey J; Eberle S; Stahl C; Mazuet C; Popoff M; Schatzmann E; Gerber V; Dungu B; Straub R Equine Vet J; 2007 Nov; 39(6):516-20. PubMed ID: 18065309 [TBL] [Abstract][Full Text] [Related]
11. Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities. Dembek ZF; Smith LA; Rusnak JM Disaster Med Public Health Prep; 2007 Nov; 1(2):122-34. PubMed ID: 18388640 [TBL] [Abstract][Full Text] [Related]
12. New targets in the search for preventive and therapeutic agents for botulism. Anniballi F; Lonati D; Fiore A; Auricchio B; De Medici D; Locatelli CA Expert Rev Anti Infect Ther; 2014 Sep; 12(9):1075-86. PubMed ID: 25089560 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Clostridium botulinum types C and D toxoid vaccination in Danish cows. Krüger M; Skau M; Shehata AA; Schrödl W Anaerobe; 2013 Oct; 23():97-101. PubMed ID: 23831724 [TBL] [Abstract][Full Text] [Related]
14. Botulinum neurotoxin vaccines: past, present, and future. Smith LA; Rusnak JM Crit Rev Immunol; 2007; 27(4):303-18. PubMed ID: 18197811 [TBL] [Abstract][Full Text] [Related]
15. Factors influencing laboratory workers' decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision-making study in CDC's anthrax vaccination program. Fowler GL; Baggs JM; Weintraub ES; Martin SW; McNeil MM; Gust DA Pharmacoepidemiol Drug Saf; 2006 Dec; 15(12):880-8. PubMed ID: 16924600 [TBL] [Abstract][Full Text] [Related]
16. Immune response of horses to vaccination with the recombinant Hc domain of botulinum neurotoxin types C and D. Stahl C; Unger L; Mazuet C; Popoff M; Straub R; Frey J Vaccine; 2009 Sep; 27(41):5661-6. PubMed ID: 19646409 [TBL] [Abstract][Full Text] [Related]
17. Botulin toxin: a weapon in terrorism. Josko D Clin Lab Sci; 2004; 17(1):30-4. PubMed ID: 15011978 [TBL] [Abstract][Full Text] [Related]
18. Clinical Study of New Tetravalent (Type A, B, E, and F) Botulinum Toxoid Vaccine Derived from M Toxin in Japan. Torii Y; Sugimoto N; Kohda T; Kozaki S; Morokuma K; Horikawa Y; Ginnaga A; Yamamoto A; Takahashi M Jpn J Infect Dis; 2017 Jul; 70(4):423-429. PubMed ID: 28250257 [TBL] [Abstract][Full Text] [Related]
19. [Botulism: prevention, clinical diagnostics, therapy and possible threat]. Gutzwiller FS; Steffen R; Mathys P; Walser S; Schmid H; Mütsch M Dtsch Med Wochenschr; 2008 Apr; 133(16):840-5. PubMed ID: 18398794 [TBL] [Abstract][Full Text] [Related]
20. The immunization of broiler chickens against type C botulism. Dohms JE; Allen PH; Cloud SS Avian Dis; 1982; 26(2):340-5. PubMed ID: 7049149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]